Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
Don’t Miss a Move in the ETF Market
Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.
BTEE ETF · iShares Nasdaq US Biotechnology UCITS ETF
Performance & flows
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | +0.58%  | -0.33%  | +42.32%  | +44.07% | +26.09% | -0.80% | +1.83% | +4.22% | |
| Flows |
Key fund info
Essentials
Enterprise
Similar ETFs
Advertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -0.33% | +42.32% | +44.07% | +26.09%  |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Exposure
Sustainability
ESG Consensus® by Conser
Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about BTEE ETF's sustainability, based on their methodology.
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
BTEE’s has a Final Sustainability Grade of either B+, B, or B-.
Replication
Issuer
| AuM | ||
|---|---|---|
IVV | iShares Core S&P 500 ETF | €736.37B |
IEFA | iShares Core MSCI EAFE ETF | €160.25B |
IEMG | iShares Core MSCI Emerging Markets ETF | €141.25B |
CSSPX | iShares Core S&P 500 UCITS ETF | €129.64B |
IWDA | iShares Core MSCI World UCITS ETF | €122.77B |
Frequently asked questions about BTEE
What does iShares Nasdaq US Biotechnology UCITS ETF, BTEE, invest in?
BTEE is a Passive ETF. This ETF provides exposure to US Equities.
Which benchmark or index does BTEE replicate?
BTEE tracks the NASDAQ Biotechnology Net Total Return Index - USD, through a full replication replication method.
What is the Total Expense ratio (TER) of BTEE?
BTEE carries a total expense ratio (TER) of 0.35%, indicating the annual cost for holding the fund.
When was BTEE launched?
BTEE was introduced to the market on March 5, 2018. It trades on France, among other exchanges
Who is the ETF issuer of BTEE?
iShares Nasdaq US Biotechnology UCITS ETF, BTEE, is provided by iShares. Learn more about iShares here.
Does BTEE have multiple share classes?
Yes, BTEE is available in multiple share classes, which may differ by distribution policy (e.g., accumulating vs. distributing), currency or hedging. Explore the different share classes .
What is the current assets under management (AUM) of BTEE?
BTEE oversees €47M in assets as of June 4, 2026.
How has BTEE performed lately?
Based on data from June 4, 2026, BTEE returned 0.58% over the past month, -0.33% over the last three months and 4.22% year-to-date.
What are the latest inflows or outflows for BTEE?
As of June 4, 2026, BTEE recorded net flows of -€79K over the last month and +€528K year-to-date.
Does BTEE distribute dividends?
BTEE follows a distributing dividend policy, meaning it pays out income to investors. As of June 4, 2026, its 12-month trailing yield was 0.36%.
What are the main country or region exposures of BTEE?
As of April 30, 2026, BTEE has significant geographic allocations in USA, United Kingdom and Bermuda.
In which sector or theme does BTEE invest in?
As of April 30, 2026, BTEE focuses largely on Health Care.
How many securities does BTEE hold and how diversified is it?
As of April 30, 2026, BTEE holds 255 positions in its portfolio, with 49.67% of assets concentrated in its top 15 holdings.
What are the main positions in BTEE?
As of April 30, 2026, BTEE top three holdings include AMGEN-T, GILEAD SCIENCES and VERTEX PHARMACEUTICALS.
What is the base currency of BTEE?
The base currency of BTEE is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
